logo-loader
Zoetic International PLC

Highlands Natural Resources teams up with chemist to develop patents for its cannabis business

Highlands has already filed the first patent through its collaboration with Stephen Goldman

cannabis
All intellectual property that is being developed will be owned by Highlands

Highlands Natural Resources PLC (LON:HNR) saw its shares rise on Tuesday following news it has appointed a chemist, Stephen Goldman as a consultant to develop and file patents on behalf of the company’s cannabis subsidiary, Zoetic.

Goldman will examine the potential medical and health benefits of combining cannabinoids with other products.

READ: HNR highlights quick move to revenue for its new CBD business

Highlands said it has already filed the first patent through its collaboration with Goldman. The patent relates to the methodology for combining cannabinoids with pharmaceutical and wellness products.

Highlands will fund the costs of the collaboration, including patent filing fees and some clinical work carried out by Goldman.

Goldman has agreed that all intellectual property that is developed will be owned by Highlands. He has been awarded options over 4mln ordinary shares in Highlands.

“Our progress at Zoetic continues at pace and we remain on track to achieve our first revenues in June from deliveries to Schrader Oil convenience stores and the launch of our own direct sales website,” said Highlands chief executive and executive chairman, Robert Price.

"Our collaboration with Stephen Goldman significantly advances our expertise in seed development and agricultural genetics and underpins our strategy to develop high quality feminised seeds for sale to hemp producers, a strategy which has significant revenue potential.”

In early afternoon trading, shares in Highlands' were 4% higher at  11.05p.

 -- Adds share price --

Quick facts: Zoetic International PLC

Price: 6.45 GBX

Market: LSE
Market Cap: £9.62 m
Follow

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Zoetic International PLC named herein, including the promotion by the Company of Zoetic International PLC in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Investor Update: Zoetic reports 'significant' first half as CBD shift continues

Headlines from the Proactive UK newsroom. Zoetic International plc (LON:ZOE) reported higher revenues in its first half as the company continued its pivot towards the cannabidiol (CBD) markets. In a trading update the firm posted revenues of £1.15mln in the six months to the end of September,...

on 4/10/19

RNS

Result of General Meeting

2 weeks, 3 days ago

Trading Update

2 weeks, 6 days ago

Issue of Equity

1 month, 1 day ago

Listing on the OTC

on 11/11/19

Issue of Equity

on 8/11/19

2 min read